Public Board of Directors papers 27.01.22

welcome. It is also recommended that the Trust considers recruiting additional FTSUGs from a diversity of backgrounds to provide choices for individuals to approach with concerns. • That the Trust reinforces the messages to staff that it is important to speak up and raise concerns; that they will be listened to and receive a reply. Timescales for receiving responses should be set and met.

• The Director of Workforce, Non-Executive Director and Chair have all reinforced the commitment to speaking up through their statement of support which is available to staff via the Trust’s intranet pages. • The Chief Executive emphasizes the importance of speaking up in his presentation at the regular Trust-wide staff inductions. • Board members have recorded individual messages in support of speaking up and can also be seen across the Trust on relevant literature and posters. • Board members have led presentations at our Grand Rounds and presentations at Management Board to continue the commitment and support to speaking up. • The Freedom to Speak up Guardian reports every six months to the BoD and to the Management Board. Raising Concerns • The Head of Engagement is working with the • Further work will be undertaken with the Board of Directors as part of the Freedom to Speak Up action plan to reinforce the commitment to speaking up. This will also include a development session for the Board. • The Trust Respect campaign continues to be implemented. Messages of zero tolerance are continually provided by members of the Board recent examples include at Grand Rounds and the EDI summit. R&I division to plan a programme of organisational development activity.

2.2.10

Raising Concerns • The Trust should invest in organisation development for the R&I Division which will fully engage staff of all grades. • The Board of Directors should reinforce its commitment to Freedom to Speak Up, and raising concerns generally, without personal detriment. • The Board of Directors should be clear in its zero tolerance of poor behaviors anywhere in the organisation.

ToR 3 - How the Trust handled allegations concerning the sharing of patient data with Roche through the Foundation Medicine (FM) programme and Flatiron in and around 2018-date. Including whether people that raised concerns suffered detriment as a result of speaking up. 2.3.2 • The Trust should review its policies and processes related to database access

• Policies for data access, use of data for research and data sharing are continuously reviewed to maintain compliance with current regulatory frameworks and maintain fitness for purpose.

ToR 4 - Whether there was a failure at the Trust to engage with clinicians in relation to commercial partnerships to ensure that: The scope and benefits were clear; The decision- making, including procurement was transparent; The risks had been identified and mitigated before any agreement was signed. 2.4.6 Project Management • That the BoD considers the full report ’Independent Assessment of the Progression of Real-World Evidence/Big Data Partnership Project Management • This document was commissioned by the Trust as part of its own review of the project and was therefore openly presented by the author to the Management Board and Medical

Opportunities at The Christie 2018- 2020’, Professor Andrew Hughes and the Non-Executive Director’s ’Freedom to Speak Up – a Review June 2, 2020’

Staff Committee together with a full action plan that was approved. It was considered by the BoD on 25 th March 2021. • The suggestions made by the Review Team

30